Navigation Links
Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
Date:5/6/2013

rnational Myeloma Workshop in April, Array presented interim results from an ongoing ARRY-520 plus Velcade combination trial, as well as results from a Phase 2 ARRY-520 single agent trial.  For patients in the combination trial, the treatment was generally well-tolerated.  Neutropenia was the most common adverse event, but was transient, non-cumulative, predominantly asymptomatic and well managed with use of growth factor support.  Incidence of non-hematologic grade 3/4 toxicity was infrequent.  Initial signs of activity, including responses and prolonged stable disease, were observed in this heavily pretreated population, the majority (72%) of whom were refractory to prior Velcade treatment.  This study will further investigate the addition of low-dose dexamethasone and an alternative dosing schedule of ARRY-520.

Final results from the Phase 2 single agent trial demonstrated clinical activity in heavily pre-treated patients.  ARRY-520 demonstrated single agent activity in heavily pretreated patients, with 19 months median Overall Survival and a 16% Overall Response Rate.  These results are similar to those for recently approved products Kyprolis® (carfilzomib) and Pomalyst® (pomalidomide) as single agents in a similar patient population.  ARRY-520 was generally well tolerated, with the most-common adverse events being transient and non-cumulative neutropenia and thrombocytopenia that were readily managed with growth factors and supportive care. In addition, there were infrequent reports of serious adverse events such as febrile neutropenia or sepsis.  Consistent with other reported ARRY-520 study results, there was a low incidence of non-hematologic adverse events with no treatment-related neuropathy observed.  Further data on a potential patient selection marker was also presented.  Patients with normal levels of alpha-1-acid glycoprotein (AAG) had a longer median overall survival (20.2 months
'/>"/>

SOURCE Array BioPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Global Array Instrument Market is Expected to Reach USD 3.2 Billion Globally in 2017: Transparency Market Research
2. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013
3. Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting
4. Array BioPharma Announces Proposed Public Offering Of Common Stock
5. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
6. Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
7. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
8. Array BioPharma To Present At The Leerink Swann Global Healthcare Conference
9. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
10. Array BioPharma To Present At The Cowen Annual Health Care Conference
11. Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... VIEJO , Kalifornien, 28. August ... hat heute den Start der Patientenrekrutierung ... Device Exemption, Forschungsausnahmegenehmigung) zur Beurteilung der ... zur Embolisation von Aneurysmen („WEB") bekanntgegeben. Adam ... of Tennessee, Department of Neurosurgery/Semmes-Murphey Clinic, ...
(Date:8/28/2014)... , Aug. 28, 2014 The ... entered a partnership to advance an experimental cancer ... (SMM), an asymptomatic stage of myeloma. ... (TAP), through which LLS forges collaborations with biotechnology ... OncoPep is developing a vaccine, ...
(Date:8/28/2014)... 2014  STAAR Surgical Company (NASDAQ: STAA ) ... delivery systems for the eye, today announced that management will ... New York Palace Hotel on Wednesday, September 3 at 7:15 ... President and CEO will offer a general overview of the ... be joined by Steve Brown , CFO, and ...
Breaking Medicine Technology:Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2
... goBalto , developer of new generation web-based clinical research solutions, ... Tufts Center for the Study of Drug Development ... there is virtually no industry data available on the typical ... that this process takes. Tufts CSDD, an independent, ...
... 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... growth in the multi-billion dollar endoscopic market.  Solos Endoscopy ... Clinics, Healthcare Centers, Medical Centers and Surgery Centers across ... instrument internationally upon receiving the CE Mark. ...
Cached Medicine Technology:goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process 2Solos Endoscopy Poised for Tremendous Growth in Multi-Billion Dollar Endoscopic Market 2
(Date:8/28/2014)... Albany, New York (PRWEB) August 28, 2014 ... is currently perceived with great interest among other healthcare ... due to the high demand in vaccine with respect ... also highly in demand due to an improved understanding ... individuals across the United States. It has led to ...
(Date:8/28/2014)... After more than two years of ... excited to announce the opening of Houston’s Mirror Mirror ... city, Mirror Mirror Beauty Boutique offers premium aesthetic services ... corner of Richmond and Drexel near Highland Village, Mirror ... cutting-edge technology in a private, easy to access location. ...
(Date:8/28/2014)... Steven Reinberg HealthDay ... Treating pre-cancerous skin spots with a type of light therapy ... the lesions with liquid nitrogen, a new study suggests. ... the scalp and face of people with fair complexions who,ve ... of prior research found that people who underwent the light ...
(Date:8/28/2014)... August 28, 2014 Genetic testing ... throughout the world, with large reference laboratories as ... laboratories differ with regard to the genetic variants ... payers may struggle to find the most appropriate ... help clients sort through these differences, Hayes, Inc. ...
(Date:8/28/2014)... Hastings and Hastings, a Phoenix Arizona accident lawyer ... industry is pleased to report having saved a client ... This is exciting news for existing clients and prospective ... proof that Hastings and Hastings stands behind its claim ... clients money when it comes to settlements and recoveries ...
Breaking Medicine News(10 mins):Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 2Health News:U.S. Vaccine Market: Opportunities and Threats by Transparency Market Research 3Health News:Mirror Mirror Beauty Boutique to Welcome Its First Patients 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 2Health News: Light Therapy a Good Option for Pre-Cancerous Skin Lesions, Study Says 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 3
... MARCH 17, 2009 The medical costs that businesses pay ... cover the costs for nearly a dozen healthy, full-term infants, ... , The average medical cost for healthy full-term babies from ... of which more than $3,800 is paid for by health ...
... 17 JumpStart Inc. , the ... of high growth early-stage businesses, and Case Technology ... technology validation fund at Case Western Reserve University ... Neuros Medical, Inc. , a Cleveland, OH company ...
... Research Group, Inc. has been covering the biologics market ... series which are syndicated primary research reports ... and Rheumatologists. The company is now expanding these ... reports which aim to compare self-reported treatment patterns ...
... device in Mexico for Minimally Invasive Treatment for ... from elite urologistsCHARLOTTE, N.C., March 16 Mexico ... and international entities of USHIFU, a global leader ... intensity focused ultrasound (HIFU) technologies, will host the ...
... Scientific, Inc. (Nasdaq: STSI ) filed its ... and Exchange Commission. The company reported 2008 net sales ... sales for 2007. However, volume sales of the company,s ... 7.8% in 2008 compared to 2007. The wholesale price ...
... /PRNewswire-Asia-FirstCall/ -- BMP,Sunstone Corporation (Nasdaq: BJGP ) ... Company is calling its $12.4 million of 10.0% Secured,Promissory ... In addition, the,Company announced the completion of the following ... million in principal amount 10.0% senior secured, ...
Cached Medicine News:Health News:Medical costs for one premature baby could cover a dozen healthy births 2Health News:Medical costs for one premature baby could cover a dozen healthy births 3Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 2Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 3Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 4Health News:JumpStart and Case Technology Ventures Invest in Neuros Medical 5Health News:BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis 2Health News:High Intensity Focused Ultrasound Physician Training Seminar in Mexico City 2Health News:Star Scientific Files Annual Financial Report 2Health News:Star Scientific Files Annual Financial Report 3Health News:Star Scientific Files Annual Financial Report 4Health News:BMP Sunstone Exchanges and Calls Outstanding Notes Due May 2009 2
... Series refrigerators from Taylor-Wharton are uniquely designed ... convenient box-type storage racks and the lower ... storage. The RackSystems are available in four ... from 750 x 2ml vials to 4800 ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
Medicine Products: